Selected article for: "post infection and time point"
Author: Aran Singanayagam; Joseph Footitt; Benjamin T Kasdorf; Matthias Marczynski; Michael T Cross; Lydia J Finney; Maria-Belen Trujillo Torralbo; Maria Calderazzo; Jie Zhu; Julia Aniscenko; Thomas B Clarke; Philip L Molyneaux; Nathan W Bartlett; Miriam F Moffatt; William O Cookson; Jadwiga Wedzicha; Christopher M Evans; Oliver Lieleg; Patrick Mallia; Sebastian L Johnston
Title: MUC5AC drives COPD exacerbation severity through amplification of virus-induced airway inflammation
  • Document date: 2019_7_22
    • ID: gg2ctmn7_16
    Snippet: Having characterised the expression of mucins during exacerbation, and noting that MUC5AC induction occurs at day 3, a time-point that precedes peak airway inflammation, which occurs between days 9 and 15 post-infection 1,15 , we next sought to assess relationships between MUC5AC responses and inflammatory responses to infection in our human experimental challenge model. We observed highly significant positive correlations between sputum MUC5AC a.....
    Document: Having characterised the expression of mucins during exacerbation, and noting that MUC5AC induction occurs at day 3, a time-point that precedes peak airway inflammation, which occurs between days 9 and 15 post-infection 1,15 , we next sought to assess relationships between MUC5AC responses and inflammatory responses to infection in our human experimental challenge model. We observed highly significant positive correlations between sputum MUC5AC and cellular airway inflammation (total cell counts and neutrophil counts, Fig.2d ) and between MUC5AC and concentrations of soluble mediators of inflammation including CXCL8/IL-8, CXCL10/IP-10, IL-1b, GM-CSF IL-6 and TNF (Fig.2d) .

    Search related documents:
    Co phrase search for related documents
    • GM CSF CXCL10 and post infection: 1
    • GM CSF CXCL10 and TNF GM CSF CXCL10: 1, 2, 3
    • human experimental challenge model and post infection: 1
    • inflammatory response and mucin expression: 1, 2, 3, 4, 5
    • inflammatory response and neutrophil count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • inflammatory response and positive correlation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • inflammatory response and post infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
    • inflammatory response and soluble mediator: 1
    • inflammatory response and TNF GM CSF CXCL10: 1, 2
    • inflammatory response and total cell count: 1, 2
    • mucin expression and positive correlation: 1
    • mucin expression and post infection: 1
    • neutrophil count and positive correlation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • neutrophil count and post infection: 1, 2
    • neutrophil count and total cell count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • neutrophil count total cell count and total cell count: 1, 2, 3, 4, 5, 6
    • positive correlation and post infection: 1, 2, 3, 4, 5, 6
    • post infection and TNF GM CSF CXCL10: 1
    • post infection and total cell count: 1